Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Raising of Funds

 Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, ('SEBI Listing Regulations') we wish to inform you that the Board of Directors at its meeting held today, i.e. on Monday, November 14, 2022, inter alia, has approved the following: 1) Issue of Redeemable, Non-Convertible Debentures aggregating up to INR equivalent of USD 250 million on private placement basis. 2) Issue of Commercial Paper up to INR equivalent of USD 275 million on private placement basis.
14-11-2022
Bigul

BIOCON LTD. - 532523 - Outcome Of Board Meeting Held On November 14, 2022

 Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, ('SEBI Listing Regulations') we wish to inform you that the Board of Directors at its meeting held today, i.e. on Monday, November 14, 2022, inter alia, has Approved the un-audited financial results (standalone and consolidated) of the Company prepared as per Indian Accounting Standard (Ind-AS) along with Limited Review Report thereon for the quarter and half-year ended September 30, 2022 along with few other matters.
14-11-2022
Bigul

BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Change in Directorate

 Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, ('SEBI Listing Regulations') we wish to inform you that the Board of Directors at its meeting held today, i.e. on Monday, November 14, 2022, inter alia, has Approved the appointment of Mr. Peter Bains as an Additional Director (Category: Non-Executive, Independent Director) of the Company w.e.f. date of activation of DIN and registration in the Independent Director's databank maintained by the Indian Institute of Corporate Affairs (IICA), whichever is later
14-11-2022
Bigul

BIOCON LTD. - 532523 - Board Meeting Outcome for Outcome Of The Board Meeting Held On November 14, 2022

 Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, ('SEBI Listing Regulations') we wish to inform you that the Board of Directors at its meeting held today, i.e. on Monday, November 14, 2022, inter alia, has Approved the un-audited financial results (standalone and consolidated) of the Company prepared as per Indian Accounting Standard (Ind-AS) along with Limited Review Report thereon for the quarter and half-year ended September 30, 2022 along with few other matters.
14-11-2022
Bigul

BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Please find enclosed the press release titled 'Biocon Biologics features in the prestigious ASIA IP ELITE List for 2022'. The above information will also be available on the website of the Company at www.biocon.com.
11-11-2022
Bigul

BIOCON LTD. - 532523 - Prior Intimation Pursuant To Regulation 29(1)(D) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 This is further to our letter dated October 20, 2022, intimating the date of the Board meeting scheduled to be held on Monday, November 14, 2022. Please be informed that the Board at the aforesaid meeting shall also consider the issue of Redeemable, Non-Convertible Debentures and / or Commercial Paper on private placement basis, amongst other matters. The above-mentioned information will also be available on website of the Company at www.biocon.com.
09-11-2022
Bigul

BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Dear Sir/Madam, Please find enclosed the press release titled 'Biocon Ranks at No. 8 in 'Global Top Employers' List by the U.S. Science Magazine'. The above information will also be available on the website of the Company at www.biocon.com. Kindly take the same on record and acknowledge.
31-10-2022

I am devastated, will always be guided by John: Biocon chief Kiran Majumdar

 Biocon Chief Kiran Majumdar-Shaw, who lost her husband, stated that she is devastated. Sharing her thoughts on social media, she maintained that she will always be guided by her husband John Shaw
25-10-2022

John Shaw, husband of Biocon chief Kiran Mazumdar Shaw, passes away

 Biocon executive chairperson Kiran Mazumdar Shaw's husband John Shaw passed away on Monday morning in a private hospital, family sources said. He was 73. Shaw was admitted to the hospital where he was undergoing treatment, they said. The exact reason behind the death was not known. Shaw was the former vice chairman of the Bengaluru-headquartered Biocon Limited. He was an MA (Economics Honours) in History and Political Economy from the University of Glasgow in United Kingdom. He was also the former chairman of Madura Coats Limited and former finance and managing director of Coats Viyella Group.
24-10-2022
Bigul

BIOCON LTD. - 532523 - Company Statement

 Dear Sir/Madam, Please find enclosed a Company Statement. The above information will also be available on the website of the Company at www.biocon.com. Kindly take the same on record and acknowledge. Thanking You,
21-10-2022
Next Page
Close

Let's Open Free Demat Account